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doi:10.1016/j.febslet.2009.04.034It has by now become a tradition for FEBS Letters to award a yearly
ten thousand euro prize to the best paper published in the journal
by a young independent scientist. This year the choice has fallen
upon Dr. Frank Sargent, Professor in Bacterial Physiology at the Uni-
versity of Dundee, Scotland, UK. The award-winning manuscript,
entitled ‘‘Features of a twin-arginine signal peptide required for rec-
ognition by a Tat proofreading chaperone” [1], was selected for its
signiﬁcant contribution to the understanding of the mechanism of
action of the twin-arginine transport system in bacteria.
What is the twin-arginine transport system?
About ten years ago, we discovered a new pathway through
which proteins can cross membranes in bacteria [2]. The unique
feature of the pathway is that it translocates fully folded proteins,
and the targeted proteins are characterized by the presence of two
arginines on an N-terminal signal peptide, which enables the rec-
ognition by the translocase machinery. The whole translocation
apparatus is thereby called the Tat (twin-arginine translocation)
system.
What is the novel ﬁnding in the award winning paper?
In the following years, we demonstrated that many Tat proteins
have speciﬁc chaperone proteins that will recognize their signal
peptides and bind to them, exerting a proofreading function [3].
The chaperone releases the Tat protein only after it has veriﬁed
that the protein is fully folded and ready to be translocated. In
the award winning study [1], we identify the residues within the
signal peptide of the Tat protein TorA (trimethylamine N-oxide
reductase) that are important for the recognition by its chaperone
(TorD) and we propose a binding mechanism. This mode of recog-
nition is likely to be a paradigm for all the Tat proteins and chap-
erones that have the same key residues in the signal peptide.
Why is it important to understand how a Tat protein and
chaperone interact?
Protein interaction is the way that proteins speak to each other
inside the cell. A speciﬁc interaction takes place amongst a hugeed by Esoup of thousands of millions of proteins. In Escherichia coli there
are 27 known proteins that use this export pathway, and that share
similar signal peptides. However, the chaperone TorD is able to
pick out TorA amongst them. It is crucial to learn how this happens.
What are your future plans regarding this project?
We are trying to solve the structure of the TorA–TorD protein
complex. The structure will reveal whether the signal peptide
changes conformation upon TorD binding, and will help under-
stand how the release of the chaperone takes place. We suspect
that a nucleotide, such as GTP, is involved in the release, but the
mechanism is still unclear.
Why did you choose to publish your work in FEBS Letters?
I had set myself the deadline to publish this study in 2008.
However, when the manuscript was ready for submission, it
was already October. FEBS Letters always had the reputation to
handle manuscripts rapidly, and also, the multidisciplinary aspect
of the study seemed to ﬁt well with the journal’s scope. FEBS Let-
ters also presents structured digital abstracts for protein–protein
interaction, which applied to our study. The structure digital ab-
stract sounded like a novel idea, and I’m all in favour of new
ideas. I hadn’t even thought about the Young Scientist Award un-
til this little box popped up while I was submitting, asking if I
wanted to participate!
I heard that you are also working on a ‘‘superbug’’ project. . .
Can you tell us a little more?
Yes, the idea is to produce hydrogen gas from E. coli, that can be
used as clean biofuel. We are trying to genetically modify the
metabolism of E. coli, so as to force all the carbon sources that it
uses towards the production of hydrogen gas. The genetically engi-
neered E. coli is what we call the superbug. In parallel, we are also
testing an in vitro system by purifying large quantities of hydrog-
enase and attaching it to an electrode. Electrons can be pumped
into the enzyme from a solar cell, and the hydrogenase will pro-
duce the gas. This last strategy seems to be the most promising
at the moment, as it can be more easily optimized, without the risk
of unpredictable reactions from the bacterium.lsevier B.V. All rights reserved.
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I spend time with my family. I enjoy taking my two young sons
to play football or to watch matches. Those are the kinds of things I
liked to do as a young boy, and I still do!
In your opinion, what are the perspectives for young scientists?
I feel they are very good. There are more and more fellowships
available that provide space and understanding for those who are
starting up a family as well as a new lab. In the UK, students ﬁnish
their studies earlier than in other parts of the world, which gives
them the chance to become independent scientists while they
are in their late twenties or early thirties. It would be nice if the
years of study were normalized around the world following the
British model, also to give everyone an equal opportunity to win
the FEBS Letters Young Scientist Award!
Would you have advice to give to young scientists applying for
grants?
In my opinion, science is driven by the curiosity of scientists,
and a new and good idea will always attract the grant referee’sattention, no matter what the governmental policies of funding
are. I would say to a young scientist: ‘‘Don’t be afraid of lateral
thinking, or to do something that has never been done before.
Don’t be afraid of asking a question that has never been asked.”
This is what we really need in science.
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